UK's Most Competitive Mounjaro vs Wegovy Pricing Comparison
Mounjaro or Wegovy Which Is Better for UK Value and Accessibility?
When comparing Mounjaro or Wegovy, pricing accessibility often determines which treatment patients can sustain long-term. EverydayMeds offers the UK's most competitive pricing structure for both prescription-only medicines, with Wegovy starting at £79.99 for the 0.25mg starter dose. Our transparent pricing includes clinical assessment, prescriber review, and next-day cold-chain delivery—eliminating hidden consultation fees that inflate costs elsewhere.
The fundamental difference lies in their mechanisms: Wegovy contains semaglutide (GLP-1 receptor agonist only), whilst Mounjaro uses tirzepatide (dual GLP-1 and GIP receptor agonist). Both require identical clinical assessment processes through our GPhC-registered pharmacy (#9012878), but storage requirements differ—Wegovy maintains potency for 6 weeks at room temperature versus Mounjaro's 21-day limit, offering practical advantages for travel and daily life.
Complete Wegovy Pricing Structure: UK's Most Competitive Rates
Our Wegovy pricing reflects genuine UK market leadership, starting with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). New customers apply discount code FIRST40 at checkout to reach these prices, whilst returning customers use DOSE25. These aren't promotional rates—they represent our standard pricing structure backed by volume procurement agreements with Novo Nordisk.
Bundle options provide convenience rather than savings, such as our Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 for complete dose escalation coverage. When considering Mounjaro or Wegovy which is better for budget planning, Wegovy's transparent five-dose escalation schedule allows precise monthly budgeting, whilst our bundles ensure uninterrupted treatment supply through the critical adjustment phases where consistency determines success.
Clinical Evidence: How Mounjaro or Wegovy Which Is Better Depends on Individual Response
Wegovy's clinical foundation stems from the STEP trial programme, where participants taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks versus 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial demonstrated 9.6% average weight loss in patients with type 2 diabetes, whilst STEP 5 showed sustained clinically studied weight loss at two years.
Mounjaro's SURMOUNT trials showed different results using tirzepatide's dual-receptor mechanism, but direct comparison isn't scientifically valid due to different trial designs, participant populations, and measurement endpoints. Both medications are prescription-only medicines requiring clinical assessment to determine individual suitability based on BMI, comorbidities, and previous treatment responses rather than published trial averages.
Understanding Wegovy's Mechanism When Comparing Mounjaro or Wegovy Which Is Better
Wegovy works as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. After injection, semaglutide binds to GLP-1 receptors in the brain's appetite centres, reducing hunger signals whilst promoting satiety after smaller meals. This mechanism may also reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. The once-weekly injection maintains consistent medication levels, avoiding the peaks and valleys of daily treatments. Clinical effectiveness requires alongside a reduced-calorie diet and increased physical activity, as Wegovy enhances rather than replaces lifestyle modifications.
Streamlined Ordering Process for Both Mounjaro or Wegovy Treatment Options
EverydayMeds simplifies access to both treatments through our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review applications within 3 working days (24-hour express service available), ensuring appropriate treatment selection whether you're considering Mounjaro or Wegovy. Once approved, medications ship via next-day delivery using temperature-controlled logistics maintaining the 2-8°C cold chain throughout transport. Our clinical team remains available for dose adjustment guidance and side effect management throughout treatment. Payment processing accepts all major cards with automatic discount code application at checkout for transparent, competitive pricing.
Practical Storage and Administration: Key Differences in Mounjaro or Wegovy Which Is Better
Both medications require refrigerated storage at 2-8°C before first use, but Wegovy offers superior room temperature stability—maintaining potency for 6 weeks below 30°C versus Mounjaro's 21-day limit. Wegovy's FlexTouch pen system provides intuitive dose selection with audible clicks confirming proper injection, whilst the mandatory dose escalation schedule (0.25mg to 2.4mg over 16 weeks) allows gradual tolerance development. Weekly injection timing should remain consistent but can be adjusted by up to 3 days if necessary for lifestyle convenience. The prescription-only medicine requires proper disposal of used pens through pharmacy return schemes rather than household waste. Dose escalation cannot be accelerated regardless of initial tolerance, as the schedule optimises both efficacy and gastrointestinal adaptation.
Why UK Patients Choose EverydayMeds for Mounjaro or Wegovy Price Comparisons
UK patients researching Mounjaro or Wegovy which is better consistently find EverydayMeds offers transparent pricing without consultation fee surprises common elsewhere. Our £79.99 Wegovy starting price includes everything: clinical assessment, prescriber review, prescription generation, medication supply, and next-day delivery. Competitor pharmacies often advertise lower headline prices then add consultation fees, express review charges, or delivery premiums that inflate total costs significantly.
Our GPhC registration (#9012878) ensures full regulatory compliance whilst our clinical team's expertise in both semaglutide and tirzepatide treatments provides informed guidance on which medication suits individual circumstances. Patient reviews consistently highlight our pricing transparency and clinical support quality, making the Mounjaro or Wegovy decision based on medical suitability rather than hidden cost concerns.
Starting Your Weight Management Journey: Mounjaro or Wegovy Application Process
Begin your assessment at https://everydaymeds.co.uk/collections/wegovy where our clinical questionnaire determines suitability for either treatment option. New customers enter discount code FIRST40 during checkout to access our competitive pricing, whilst returning customers use DOSE25 for continued savings. Our prescribers evaluate both Mounjaro and Wegovy options based on your individual health profile, ensuring evidence-based treatment selection rather than patient preference alone. Express 24-hour prescriber review ensures rapid treatment commencement once clinical suitability is confirmed. Remember that both medications are prescription-only medicines requiring ongoing medical supervision and lifestyle modification commitment for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
